Skip to main content
. 2016 Nov 23;16(11):1909. doi: 10.3390/s16111909

Figure 3.

Figure 3

Selectivity study of various probe (RS; random sequence, EpCAM ALB, antibody, and mutant) against different cell lines including EpCAM-positive cell lines: (A) breast cancer cell line MDA-MB-231; (B) human gastric carcinoma cell line Kato III; and (C) negative cell line human kidney epithelial cell line HEK-293T.